577 related articles for article (PubMed ID: 29471781)
1. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
Maiti P; Paladugu L; Dunbar GL
BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
[TBL] [Abstract][Full Text] [Related]
2. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis.
Maiti P; Bowers Z; Bourcier-Schultz A; Morse J; Dunbar GL
Alzheimers Res Ther; 2021 Feb; 13(1):37. PubMed ID: 33557949
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer's Disease.
Maiti P; Manna J; Burch ZN; Flaherty DB; Larkin JD; Dunbar GL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933008
[TBL] [Abstract][Full Text] [Related]
5. Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to A
Maiti P; Dunbar GL
Int J Alzheimers Dis; 2017; 2017():4164872. PubMed ID: 28567323
[TBL] [Abstract][Full Text] [Related]
6. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
7. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
[TBL] [Abstract][Full Text] [Related]
8. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
9. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin.
Maiti P; Plemmons A; Bowers Z; Weaver C; Dunbar G
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736502
[TBL] [Abstract][Full Text] [Related]
10. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
Moon M; Cha MY; Mook-Jung I
J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer's Disease.
Paladugu L; Gharaibeh A; Kolli N; Learman C; Hall TC; Li L; Rossignol J; Maiti P; Dunbar GL
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467075
[TBL] [Abstract][Full Text] [Related]
13. A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer's Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model.
Su IJ; Chang HY; Wang HC; Tsai KJ
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751716
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
15. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
[TBL] [Abstract][Full Text] [Related]
16. Immune Suppression of Glia Maturation Factor Reverses Behavioral Impairment, Attenuates Amyloid Plaque Pathology and Neuroinflammation in an Alzheimer's Disease Mouse Model.
Ahmed ME; Selvakumar GP; Thangavel R; Kempuraj D; Raikwar SP; Zaheer S; Iyer S; Zaheer A
J Neuroimmune Pharmacol; 2021 Jun; 16(2):363-375. PubMed ID: 32504312
[TBL] [Abstract][Full Text] [Related]
17. Catalpol rescues cognitive deficits by attenuating amyloid β plaques and neuroinflammation.
Li S; Tian Z; Xian X; Yan C; Li Q; Li N; Xu X; Hou X; Zhang X; Yang Y; Xue S; Ma S; Cui S; Sun L; Yao X
Biomed Pharmacother; 2023 Sep; 165():115026. PubMed ID: 37336148
[TBL] [Abstract][Full Text] [Related]
18. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
19. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
[TBL] [Abstract][Full Text] [Related]
20. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
